VivekKumar Postgraduate Institute of Medical Education and Research, Chandigarh, IndiaIndia

VivekKumar
Dr Vivek Kumar is working as Associate Professor of Nephrology at the Postgraduate Institute of Medical Education and Research at Chandigarh in India. His research interests include epidemiology and outcomes in CKD and AKI. He is an India Alliance Clinical and Public Health Intermediate Fellow (Department of Biotechnology, Government of India and Wellcome Trust, UK). He has experience in setting up multi-centric cohort studies and clinical trials in India.
Upload Picture
https://storage.unitedwebnetwork.com/files/1099/5e15360dc5e75ca34cb2b91cf1e8adf3.jpeg
First Name
Vivek
Last Name
Kumar
Institution
Country.
India

Friday, February 7, 2025

Time Session
9:45 a.m.
11:15 a.m.
Hot Topics From the Tropics
SabineKaram Chair University of MinnesotaUnited States
SourabhSharma Chair Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, IndiaIndia
  • Best Abstract Winner - Basic Science: miRNA Profiling of Urinary Exosomes for Predicting Renal Outcome After Acute Kidney Injury: A Pilot Study
    JaskiranKaur Oral Abstract Presenter Department of Experimental Medicine and BiotechnologyIndia
  • Best Abstract Winner - Clinical Science: Randomised Controlled Trial Comparing Rituximab to Mycophenolate Mofetil in Children and Young Adults With Steroid-Dependent Idiopathic Nephrotic Syndrome
    AndreaAngeletti Oral Abstract Presenter Italy
  • Q and A
  • Everything You Ever Wanted to Know About Tropical Infections and the Kidney
    MythriShankar Speaker Institute of NephrourologyIndia
  • Challenges in the Tropics: When CKDu Becomes Less Unknown
    ErangaWijewickrama Speaker Faculty of Medicine, University of ColomboSri Lanka
  • Roundtable Discussion
    BiancaDavidson Speaker Groote Schuur Hospital, University of Cape TownSouth Africa
    ErangaWijewickrama Speaker Faculty of Medicine, University of ColomboSri Lanka
    MythriShankar Speaker Institute of NephrourologyIndia
    SourabhSharma Speaker Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, IndiaIndia
    VivekKumar Speaker Postgraduate Institute of Medical Education and Research, Chandigarh, IndiaIndia
Champa Hall 304
2:15 p.m.
3:45 p.m.
HIT! High Impact Clinical Trials – What and Why
AndreaViecelli Chair University of QueenslandAustralia
VivekKumar Chair Postgraduate Institute of Medical Education and Research, Chandigarh, IndiaIndia
  • Combination Effect of Finerenone and Empagliflozin in Participants With Chronic Kidney Disease and Type 2 Diabetes Using a UACR Endpoint Study (CONFIDENCE)
    RajivAgarwal Oral Abstract Presenter United States
  • Results From the REGENCY Trial Assessing Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
    BradRovin Oral Abstract Presenter The Ohio State UniversityUnited States
  • Clinical and Safety Outcomes of Semaglutide by CKD Severity in the FLOW trial
    KatherineTuttle Oral Abstract Presenter University of Washington School of Medicine, Division of NephrologyUnited States
Brahmkamal Hall - Plenary Hall

Saturday, February 8, 2025

Time Session
9:45 a.m.
11:15 a.m.
Toward Complex Understanding of Kidney Function in AKI: Role of Biomarkers, Sex Differences and the Tropics; ISN-KSN Joint Session
GirishNarayen Chair Chief of Nephrology division, udaiomni hospital, Hyderabad,IndiaIndia
Hyeong CheonPark Chair Hyeong Cheon Park, Gangnam Severance Hospital, Yonsei UniversityKorea (Republic of)
Prem PVarma Chair Principal DirectorIndia
  • What Do We Know About the Association Between AKI and Long-Term Adverse Outcomes?
    Chi-yuanHsu Speaker University of California, San FranciscoUnited States
  • Are Biomarkers in AKI Ready for Prime Time?
    ChiragParikh Speaker Johns Hopkins University United States
  • Community-acquired AKI in the Tropics - Is it a Different Disease?
    VivekKumar Speaker Postgraduate Institute of Medical Education and Research, Chandigarh, IndiaIndia
  • Sex as a Biological Variable in the Epidemiology of AKI
    MarliesOstermann Speaker King's College LondonUnited Kingdom
  • Q&A
Amaltas Hall B101-A